Ivica Zubac (LA Clippers) with a dunk vs the Indiana Pacers, 04/13/2021
Ivica Zubac (LA Clippers) with a dunk vs the Indiana Pacers, 04/13/2021
German carmaker BMW plans to unveil a limited series hydrogen fuel cell model SUV in 2022 as the company continues to research zero-emission alternatives to battery-electric cars, the company's top executive said on Wednesday. Speaking at the carmaker's annual shareholder meeting, Chief Executive Officer Oliver Zipse said the company plans a small production run of a hydrogen fuel-cell powered x5 SUV next year. But BMW is one of a small number of carmakers that currently sees possibilities for the mass adoption of hydrogen fuel cells, which emit only water, and has said it is keeping its options open for the future.
TV celebrity stylist Lalla Bronshtein shares her top tips.
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) ("Columbia Care" or the "Company"), one of the largest and most experienced cultivators, manufacturers and providers of medical and adult-use cannabis products, today announced the launch of its new retail brand, Cannabist. More than a dispensary, Cannabist will serve as the intersection for medical and recreational cannabis users to provide a higher experience built on one of the largest customer data repositories, passion, technology innovation, community commitment and product standards.
The stars were out in force at Tuesday night's event, serving up some seriously stylish looks.
Engineers are almost done building and testing the successor to the Hubble Space Telescope.
Who's behind the fake Instagram?
The company also revised its guidance, raising its net profit forecast but lowering sales and operating forecasts
NephroDI Therapeutics, Inc. today announced a seed investment from Xontogeny, LLC to advance their lead program through critical preclinical work.
Carvana Brings The New Way to Buy a Car® to Monroe.
The "Hydrazine Hydrate Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
Nephraegis Therapeutics announces their launch with a seed investment from Xontogeny to advance their lead compound through critical preclinical work
Peroxitech today announced their launch with a seed investment from Xontogeny to advance their lead program through completion of IND-enabling work.
Tellus Therapeutics, Inc. today announced a seed investment from Xontogeny, LLC to advance their lead program through IND-enabling work.
Dominic Raab criticises Russia for "sheltering" criminals, in a keynote speech on cyber-security.
Former minister Lord Johnson’s comments came as the Government prepared to legislate on campus free speech in England.
DUBLIN, Ohio (AP) _ Wendy's Co. (WEN) on Wednesday reported first-quarter earnings of $41.4 million. On a per-share basis, the Dublin, Ohio-based company said it had profit of 18 cents. Earnings, adjusted for non-recurring costs, were 20 cents per share. The results beat Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 14 cents per share. The hamburger chain posted revenue of $460.2 million in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $444.1 million. Wendy's expects full-year earnings in the range of 72 cents to 74 cents per share. Wendy's shares have risen 4% since the beginning of the year. The stock has increased 8% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WEN at https://www.zacks.com/ap/WEN The Associated Press
BRUSSELS (AP) — In the latest setback to European Union efforts to tackle corporate tax avoidance, a court on Wednesday annulled a ruling by the European Commission that a tax deal between the Luxembourg government and Amazon amounted to illegal state support. The EU's executive branch ordered the U.S. online retailer in 2017 to pay around 250 million euros ($300 million) in back taxes to Luxembourg. But judges at the EU's General Court said the European Commission didn't prove “to the requisite legal standard that there was an undue reduction of the tax burden of a European subsidiary of the Amazon group." Amazon said it welcomed the court’s decision, which is “in line with our long-standing position that we followed all applicable laws and that Amazon received no special treatment,” the company said in a statement. “We’re pleased that the Court has made this clear, and we can continue to focus on delivering for our customers across Europe.” The European Commission's decision related to Luxembourg’s tax treatment of two companies in the Amazon group: Amazon EU and Amazon Europe Holding Technologies. Margrethe Vestager, the EU official in charge of antitrust issues, argued at the time that Amazon had unfairly profited from special low tax conditions since 2003 in tiny Luxembourg, where its European headquarters are based. As a result, almost three quarters of Amazon’s profits in the EU were not taxed, she said. Vestager didn't reply immediately to a request for comment. Both Luxembourg and Amazon challenged the decision with the EU's General Court. The EU has taken aim at deals concluded between individual countries and companies used to lure foreign multinationals in search of a place to establish their EU headquarters. The practice led to EU states competing with each other and multinationals playing them off one another. Judges at the General Court have backed the European Commission in several cases, but the EU's efforts to crack down on favorable tax deals suffered recent setbacks in cases involving Starbucks and Apple. Wednesday's ruling can be appealed to the 27-nation bloc's highest court, the European Court of Justice. The EU remains at odds with Amazon on other issues relating to competition. Last year, EU regulators filed antitrust charges against the e-commerce company, accusing Amazon of using its access to data from companies that sell products on its platform to gain an unfair advantage over them. In another judgment Wednesday, the General Court found the existence of a tax advantage in rulings granted by Luxembourg to companies in the Engie group, a French multinational electric utility company. Three years ago, the European Commission had found that Luxembourg allowed two Engie group companies to avoid paying taxes on almost all their profits for about a decade and said the country should recover about 120 million euros in unpaid tax. The Luxembourg government welcomed the Amazon decision and said in a statement that neither ruling calls into question the country's “commitment to transparency in tax matters and the fight against tax avoidance practices.” ___ Kelvin Chan contributed to this story from London. Samuel Petrequin, The Associated Press
CLEARWATER, Fla. (AP) _ Apyx Medical Corporation (APYX) on Wednesday reported a loss of $4.9 million in its first quarter. On a per-share basis, the Clearwater, Florida-based company said it had a loss of 14 cents. The medical device maker posted revenue of $8.6 million in the period. Apyx expects full-year revenue in the range of $37.6 million to $39.7 million. Apyx shares have climbed 32% since the beginning of the year. The stock has more than doubled in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on APYX at https://www.zacks.com/ap/APYX The Associated Press
On a Fool Live episode recorded on April 28, Fool contributors Brian Feroldi, Brian Stoffel, and Brian Withers discuss how to think about this 90-day business checkpoint and the resulting market moves. Teladoc is still lapping early phases of the coronavirus. You never know whether Teladoc or a company coming out with earnings is going to have one little thing that people sort of latch onto and call it a kind of a rough quarter.
Dublin, May 12, 2021 (GLOBE NEWSWIRE) -- The "China Infant Formula Market: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com's offering. The report provides analysis of the China infant formula market, with detailed analysis of market size and growth of the industry. The analysis includes the market by value, by volume, by segmentation and by products. China is a major contributor to the infant formula market at the global level and is supported by increased population in China after withdrawal of one child policy by the Government of China in 2013 and increased income of middle class population.The China infant formula market has increased at a significant CAGR during the years 2016-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. China infant formula market is expected to increase due many growth drivers such as high female workforce share, rising middle class & dual income families, increasing expenditure on premium nutrition, etc. yet the market faces some challenges such as declining new birth in china, foreign brands dominating the market, etc. global hyper converged infrastructure market is expected to observe some new market trends such as gaining popularity by goat milk instant formula, favorable policies for domestic brands, etc.Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall China infant formula market has also been forecasted for the years 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.Nestle, Danone, Abbott Laboratories and Feihe International Inc. are some of the key players operating in the China infant formula market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.Company Coverage NestleDanoneAbbott LaboratoriesFeihe International Inc. Key Topics Covered: 1. Executive Summary2. Introduction2.1 Infant Milk Formula: An Overview2.1.1 Infant Milk Formula2.1.2 Infant Milk Formula Production Process2.1.3 Types of Infant Milk Formula2.1.4 Infant Milk Formula: Value Chain2.1.5 Advantages of Infant Milk Formula2.1.6 Infant Milk Formula: Based on Type of Availability3. Global Market Analysis3.1 Global Infant Formula Market: An Analysis3.1.1 Global Infant Formula Market by Value3.1.2 Global Infant Formula Market by Volume3.1.3 Global Infant Formula Market by Region (China and ROW)4. China Market Analysis4.1 China Infant Formula Market: An Analysis4.1.1 China Infant Formula Market by Value4.1.2 China Infant Formula Market by Value Growth Rate4.1.3 China Infant Formula Market by Volume4.1.4 China Infant Formula Market by Volume Growth Rate4.1.5 China Infant Formula Market by Average Selling Price (ASP)4.1.6 China Infant Formula Market by Average Selling Price (ASP) Growth Rate4.2 China Infant Formula Market: Segment Analysis4.2.1 China Infant Formula Market by Segment (Ultra-High End, High End, Mid-To-High End, Mid End and Low End)4.2.2 China Infant Formula Market Segments by Value4.3 China Infant Formula Market: Product Analysis4.3.1 China Infant Formula Market by Product (Goat Infant Formula, Organic Infant Formula, A2 Infant Formula and Others)4.3.2 China Goat Infant Formula by Value4.3.3 China Organic Infant Formula by Value4.3.4 China A2 Infant Formula by Value4.3.5 China Infant Formula Products by CAGR Comparison4.4 China Infant Formula Market: Distribution Channel Analysis4.4.1 China Infant Formula Market Distribution Channel by Share5. Market Dynamics5.1 Growth Drivers5.1.1 High Female Workforce Share5.1.2 Rising Middle Class & Dual Income Families5.1.3 Increasing Expenditure on Premium Nutrition5.1.4 Reason for Infant Formula Purchase5.1.5 High Preference for Imported Brands5.1.6 Lower-tier Cities Are Targeted For The Expansion Of Milk Formula5.2 Challenges5.2.1 Declining New Birth in China5.2.2 Foreign Brands Dominating the Market5.3 Market Trends5.3.1 Gaining Popularity by Goat Milk Instant Formula5.3.2 Favorable Policies for Domestic Brands5.3.3 Growing Opportunity for Liquid Infant Formula5.3.4 Infant Formula for Occasions5.3.5 Rising Infant Formula Imports6. Competitive Landscape6.1 China Infant Formula Market: Competitive Analysis 6.1.1 China Infant Formula Market Share by Player7. Company Profile7.1 Nestle7.1.1 Business Overview7.1.2 Financial Overview7.1.3 Business Strategy7.2 Danone7.3 Abbott Laboratories7.4 Feihe International Inc. For more information about this report visit https://www.researchandmarkets.com/r/5qnnaf CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900